Aseptic Meningitis Syndrome With Immunoglobulin Therapy

Aseptic meningitis syndrome (AMS) is a recognized but relatively rare adverse event associated with intravenous immunoglobulin (IVIG) therapy and less commonly with subcutaneous immunoglobulin (SCIG) therapy.^1,2

Although rare, AMS occurs in approximately 0.6% to 1% of patients receiving IVIG,